What is GELS's current stock price?

GELS (Gelteq Limited Ordinary Shares) is currently trading at $0.42 with a market cap of $3.9M.

What sector is Gelteq Limited Ordinary Shares in?

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

InvestLog

GELS Gelteq Limited Ordinary Shares

Healthcare

$0.42-3.21%ClosedMarket Cap: $3.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.00

P/S

32.62

EV/EBITDA

-2.63

DCF Value

$-0.28

FCF Yield

-114.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

100.0%

Operating Margin

-3317.7%

Net Margin

-4011.9%

ROE

-43.0%

ROA

-30.9%

ROIC

-27.4%

Financials

View All

Period	Revenue	Net Income	EPS
FY null	$165.6K	$-6.6M	$—
Q4 null	$0.00	$-1.1M	$—
FY null	$0.00	$-3.5M	$—
Q3 null	$0.00	$-727.4K	$—

Trading Activity

Insider Trades

View All

WYNNE Paul Michaelofficer

SellWed Mar 18

Szewach Simon Hdirector

SellWed Mar 18

Szewach Simon Hdirector

SellWed Mar 18

Karp Bradley Glennofficer: Head of Sales and Marketing

SellWed Mar 18

Givoni Nathan Jofficer: Chief Executive Officer

SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

0.08

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Peers